|
Synonym(s):
|
Enzyme
Immunoassay (EIA) for the Detection of total Anti-Hepatitis A Antibodies (IgG
and IgM) in Human Serum
|
|
Requisition Form
|
G-2A
|
|
Test Description
|
An
in vitro enzyme immunoassay for the qualitative detection of total antibodies
(IgG and IgM) to hepatitis A virus in human serum
|
|
Pre-Approval Needed
|
N/A
|
|
Supplemental Information Required
|
N/A
|
|
Supplemental Form(s)
|
N/A
|
|
Performed on Specimens from (sources)
|
Human
|
|
Sample/Specimen Type for Testing
|
Serum
|
|
Minimum Volume/Size Required
|
500 µL
|
|
Storage/Preservation Prior to Shipping
|
Serum
separated from the clot may be stored at 2°C to 8°C for up to 48 hours but
then must be frozen at -20°C or colder until used.
|
|
Transport Medium
|
N/A
|
|
Specimen Labeling
|
At least 2 patient specific identifiers: First
and last name as one identifier and a DOB or a unique patient specific
identifier (e.g. Medical Record number); must match information on submission form (G-2A).
|
|
Shipping and Specimen Handling Requirements
|
- Ship according to Dangerous Goods Regulations,
IATA, and/or CFR 49.
- Handle as infectious agent using universal
precautions.
- Triple contain in accordance with federal
shipping regulations for infectious agents.
Additional
forms & resources
|
|
Method
|
EIA for antibody detection
|
|
Turn-around Time
|
5 days
|
|
Interferences/Limitations
|
Bacterial contamination,
heterophile antibodies
|
|
Causes for Rejection
|
Insufficient quantity, unacceptable
specimen type or source, improper shipping conditions, expired media or
collection container, discrepancies between specimen label and submission
form, and/or incomplete or missing submission form.
|
|
Additional Information
|
A
reactive HAV result does not exclude co-infection by another hepatitis virus.
|